Switch to:
More From Other Websites
PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Dec 12 2014
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement Dec 10 2014
BioMarin's VIMIZIM(R) (elosulfase alfa) Approved in Brazil for Treatment of Morquio A Syndrome Dec 10 2014
FDA Grants BioMarin Orphan Drug Designation for NAGLU Fusion Protein, BMN 250, for the Treatment of... Dec 10 2014
BioMarin's VIMIZIM(R) (elosulfase alfa) Approved in Brazil for Treatment of Morquio A Syndrome Dec 10 2014
FDA Grants BioMarin Orphan Drug Designation for NAGLU Fusion Protein, BMN 250, for the Treatment of... Dec 10 2014
BioMarin to Highlight Breadth of Innovative Development Pipeline at Analyst and Investor Day on... Dec 09 2014
BioMarin to Highlight Breadth of Innovative Development Pipeline at Analyst and Investor Day on... Dec 09 2014
BioMarin's VIMIZIM(R) (elosulfase alfa) Approved in Australia for Treatment of Morquio A Syndrome Dec 07 2014
Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta Dec 05 2014
Rare disease biotech deal Dec 03 2014
BioMarin to Host Analyst and Investor Day on December 10th in New York Dec 03 2014
BioMarin to Host Analyst and Investor Day on December 10th in New York Dec 03 2014
Jim Cramer's Top Stock Picks: REGN BMRN ISIS EOG BIIB CELG DECK ZOES Dec 03 2014
RBC's biotech picks: CELG, BMRN & VRTX Dec 02 2014
7 Biotech stocks to buy now Dec 02 2014
Transforming Biotech Coal to Gold: A Look At Puma, BioMarin and Cellceutix Dec 02 2014
KaloBios Elects Robert A. Baffi, BioMarin Senior Executive, to Board of Directors Dec 01 2014
The Zacks Analyst Blog Highlights: BioMarin, Prosensa, Five Prime Therapeutics, AbbVie, Amgen,... Nov 28 2014
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Nov 26 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK